<DOC>
	<DOCNO>NCT02039011</DOCNO>
	<brief_summary>Asthma common condition produce significant workload general practice , hospital outpatient clinic inpatient admission . Asthma cause inflammation airway irritate muscle around airway cause constrict . The mainstay asthma treatment inhaled steroid . If patient ' symptom still adequately control , long-acting beta agonist ( LABA ) inhaler relaxes muscle airway open frequently add inhaled steroid . Despite , substantial proportion asthmatic patient still achieve adequate control symptom . Recent study show alternative inhaler call long-acting muscarinic antagonist ( LAMA ) add LABA - reduce number asthma exacerbation ( flare-up ) improve airway narrow . The mannitol challenge test airway 'twitchiness ' , important feature asthma . There previous study assess combined effect LABA LAMA inhaler mannitol challenge . The mannitol challenge particularly relevant mimic stimuli encounter real life provoke asthma attack . The investigator propose directly compare indacaterol , new once-daily LABA indacaterol plus tiotropium , once-daily LAMA , add-on treatment inhaled steroid persistent asthmatic use mannitol challenge . The investigator hope study help u understand combination LABA LAMA might help protect flare-up .</brief_summary>
	<brief_title>Ultra-long Acting Bronchodilator Therapy Asthmatics</brief_title>
	<detailed_description />
	<mesh_term>Mannitol</mesh_term>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Male female volunteer age least 16 year persistent asthma inhaled corticosteroid ( least 400 microgram beclomethasone dipropionate equivalent FEV1 &gt; 50 % predict Mannitol PD15 &lt; 635 mg Ability give inform consent Agreement general practitioner make aware study participation receive feedback relevant participant 's well Other respiratory disease chronic obstructive pulmonary disease , bronchiectasis allergic bronchopulmonary aspergillosis An asthma exacerbation respiratory tract infection require systemic steroid and/or antibiotic within 3 month study commencement Any clinically significant medical condition may endanger health safety participant Smoking within one year &gt; 10 pack year history Participation another trial within 30 day commencement study Pregnancy lactation Unable comply procedure protocol</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Long act beta-agonists</keyword>
	<keyword>Long act muscarinic antagonist</keyword>
	<keyword>Mannitol challenge</keyword>
</DOC>